Capital Impact Advisors, LLC Jazz Pharmaceuticals PLC Transaction History

Capital Impact Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $1.4 Million - $2.43 Million	-15,923 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $1.87 Million - $2.45 Million	15,923 New	15,923 $2.38 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $963,760 - $1.1 Million	-7,699 Closed	0 $0
Q1 2018 Apr 11, 2018	BUY	$135.59 - $157.16 $277,281 - $321,392	2,045 Added 36.17%	7,699 $1.16 Million
Q3 2017 Jan 16, 2018	BUY	$142.62 - $155.6 $806,373 - $879,762	5,654	5,654 $827,000

511

57.7M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.32B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.